Management Team
C.E. "Rick" Strattan
Chairman, Chief Executive Officer
Mr. Strattan has been President/CEO and Chairman of CTDH since its reorganization in 1994. He served as all the officers of the Florida C-corp. from August 1990 to May 1994. From November 1987 through July 1992, Mr. Strattan was with Pharmatec, Inc. where he became Director of Marketing and Business Development for CDs. He was responsible for CD sales and related business development efforts. From November, 1985 through May, 1987 he served as Chief Technical Officer for Boots-Celltech Diagnostics, Inc. He also served as Product Sales Manager for American Bio-Science Laboratories, a Division of American Hospital Supply Corporation.
Mr. Strattan is a graduate of the University of Florida with a BS degree in chemistry and mathematics and has also received an MS degree in Pharmacology and an MBA degree in Marketing/Computer Information Sciences from the same institution. Mr. Strattan has written and published numerous journal and white paper articles and a book chapter on the subject of cyclodextrins.
Dr. Jeffrey L. Tate
Director, Executive Vice President
Dr. Tate is a seasoned executive with 20+ years of accomplishment in the biotechnology, pharmaceutical and nutritional supplements industries including: branded generic drugs, intellectual property strategy, product development, and cGMP manufacturing. He is confidently familiar with food and drug marketing approval procedures, documentation and strategy in U.S. and foreign markets.
Dr. Tate has served as Associate Director of the Biotechnology Institute at the University of Minnesota, Chairman of the National Council of Biotechnology Centers, Sr. V.P. for Regulatory and Scientific Affairs at a start-up biopharmaceutical company, President and General Manager of Pulse Combustion Systems and now joins CTD Holdings, Inc. as Exec. V.P. & Director of the holding company and President and CEO of three of the wholly owned subsidiaries: NanoSonic Products, Inc.; Sphingo Biotech, Inc., and Ferrazo Environmental Technology, Inc.
Dr. Tate brings his depth of experience to bear on building expanded manufacturing systems to position CTD Holdings, Inc. as the global leader in specialty cyclodextrins, cyclodextrin derivatives, and cyclodextrin complexes.
George L. Fails
Director, Operations Manager
Mr. Fails has served as served as Director of Operations for CTD Holdings Inc. since 2000 and was appointed president of CTD Inc. (wholly owned subsidiary of CTDH) in 2008. From 1965 until his retirement in 1986, Mr. Fails served with the US Army Special Forces reaching the rank of sergeant major. Mr. Fails received his BA from the University of the Philippines, and also received degrees from 43 Military schools and the Federal Police Academy in Little Rock, Arkansas. Prior to joining the Company, Mr. Fails served as a Detective Sergeant with the Veterans Administration Hospital in Gainesville, Florida; and had special duties as an Officer with the US Marshall’s Service.
